Alterity Therapeutics (ATHE) Common Equity (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Common Equity of $35.6 million for Q4 2025, up 599.79% year-over-year from $5.1 million in Q4 2024, and up 31.21% quarter-over-quarter from $27.2 million in Q2 2025.
Alterity Therapeutics (ATHE) Common Equity (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Common Equity history runs 17 years deep, the most recent figure standing at $35.6 million for Q4 2025.
- In Q4 2025, Common Equity rose 599.79% year-over-year to $35.6 million; the TTM figure through Dec 2025 stood at $35.6 million (up 599.79% YoY), while the FY2025 annual figure was $27.2 million, up 119.24% from the prior year.
- Common Equity for Q4 2025 stood at $35.6 million, up from $27.2 million in the prior quarter.
- The five-year high for Common Equity was $35.6 million in Q4 2025, with the low at $228129.1 in Q2 2023.
- The 5-year median for Common Equity is $21.0 million (2021), against an average of $19.0 million.
- The sharpest annual moves came in 2023 and 2024: Common Equity slumped 99.1% in 2023, then surged 5560.24% in 2024.
- Alterity Therapeutics' Common Equity stood at $30.0 million in 2021, then plunged by 38.37% to $18.5 million in 2022, then sank by 37.87% to $11.5 million in 2023, then plunged by 55.62% to $5.1 million in 2024, then soared by 599.79% to $35.6 million in 2025.
- Business Quant data shows ATHE's Common Equity at $35.6 million in Q4 2025, $27.2 million in Q2 2025, and $5.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.79 Bn |
| 10 | Alterity Therapeutics | 48.08 Mn | 15.78 Mn | - | 35.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.63 Mn |
| Jun 30, 2025 | 27.16 Mn |
| Dec 31, 2024 | 5.09 Mn |
| Jun 30, 2024 | 12.91 Mn |
| Dec 31, 2023 | 11.47 Mn |
| Jun 30, 2023 | 228,129.09 |
| Dec 31, 2022 | 18.46 Mn |
| Jun 30, 2022 | 25.41 Mn |
| Dec 31, 2021 | 29.96 Mn |
| Jun 30, 2021 | 23.46 Mn |
| Dec 31, 2020 | 25.11 Mn |
| Jun 30, 2020 | 4.69 Mn |
| Dec 31, 2019 | 7.65 Mn |
| Jun 30, 2019 | 11.60 Mn |
| Dec 31, 2018 | 7,836.19 |
| Jun 30, 2018 | 12.17 Mn |
| Dec 31, 2017 | 15.47 Mn |
| Jun 30, 2017 | 17.80 Mn |
| Dec 31, 2016 | 20.68 Mn |
| Jun 30, 2016 | 23.42 Mn |